Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Aggression × Etoposide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 137 Leukemia 86 Lymphoma, Large B-Cell, Diffuse 82 Precursor Cell Lymphoblastic Leukemia-Lymphoma 79 Lymphoma, Non-Hodgkin 78 Hodgkin Disease 67 Leukemia, Myeloid, Acute 64 Lymphoma, Follicular 54 Burkitt Lymphoma 52 Lymphoma, Large-Cell, Immunoblastic 49 Lymphoma, Mantle-Cell 45 Small Cell Lung Carcinoma 39 Leukemia, Lymphocytic, Chronic, B-Cell 38 Lung Neoplasms 35 Lymphoma, B-Cell, Marginal Zone 30 Neuroblastoma 28 Congenital Abnormalities 26 Multiple Myeloma 24 Central Nervous System Neoplasms 24 Sarcoma 21 Recurrence 21 Leukemia, Monocytic, Acute 21 Leukemia, Erythroblastic, Acute 21 Myelodysplastic Syndromes 20 Leukemia, Myelomonocytic, Acute 20 Brain Neoplasms 20 Leukemia, Megakaryoblastic, Acute 19 Dendritic Cell Sarcoma, Interdigitating 19 Carcinoma, Non-Small-Cell Lung 18 Testicular Neoplasms 17

Interventions

vandetanib 1 selinexor 1 pegfilgrastim 1 midostaurin 1 Topotecan 1 Rituximab 1 Prednisone 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡